UK researchers part of EU-funded antimicrobial resistance projects
UK researchers are involved in six of 15 new antimicrobial resistance research projects funded by the EU and announced by the European Commission today to mark European Antibiotic Awareness Day (18 November 2013).
According to the EC, growing antimicrobial resistance is estimated to cause some 25,000 deaths annually and costs Europe more than £1.28bn in healthcare expenses and productivity losses.
Three of the projects are being co-ordinated at the universities of Oxford and Manchester, and Royal Holloway and Bedford New College, which is working on an oral vaccine against the hospital bacterium Clostridium difficile. A further three projects involve UK researchers at the University of Cork, Ireland, Erasmus University in Rotterdam, the Netherlands, and the Pasteur Institute in Paris, France.
“Research and innovation are essential if we are to turn the tide against antimicrobial resistance,” said European Commissioner for Research and Innovation Máire Geoghegan-Quinn. “These new projects will add to the excellent work ongoing to develop new drugs and treatments."
During the past 16 years, the EU has invested some £685m in research and innovation to fight antimicrobial resistance, including the 15 research projects announced today.
Citation: The Pharmaceutical Journal URI: 11130460
Recommended from Pharmaceutical Press
This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.£57.00Buy now
Standards for unlicensed aseptic preparation in the UK, as well as practical information for implementing the standards.£46.00Buy now